Recombinant shark antibody specifically binds to Plasmodium falciparum AMA1, expressed in Chinese Hamster Ovary cells(CHO).
Figure 1 V(NAR)s 12Y-1 and 12Y-2 are specific for P. falciparum AMA1.
ELISA comparison of binding of affinity purified proteins 12Y-1 (black) and 12Y-2 (grey) to lysozyme, AMA1, -amylase, and Tom70.
Nuttall, S. D., Humberstone, K. S., Krishnan, U. V., Carmichael, J. A., Doughty, L., Hattarki, M., ... & Irving, R. A. (2004). Selection and affinity maturation of IgNAR variable domains targeting Plasmodium falciparum AMA1. PROTEINS: Structure, Function, and Bioinformatics, 55(1), 187-197.
Figure 2 ELISA of V(NAR) 12Y-2 by error-prone PCR.
After three rounds of panning, 16 affinity-matured clones were tested for binding to AMA1 and to lysozyme (negative control antigen). The hatched line represents the parental (12Y-2) response level.
Nuttall, S. D., Humberstone, K. S., Krishnan, U. V., Carmichael, J. A., Doughty, L., Hattarki, M., ... & Irving, R. A. (2004). Selection and affinity maturation of IgNAR variable domains targeting Plasmodium falciparum AMA1. PROTEINS: Structure, Function, and Bioinformatics, 55(1), 187-197.
Figure 3 The 12Y-2 triple-mutant shows parental affinity for AMA1.
BIAcore sensorgrams comparing the binding of identical concentrations of the parental (12Y-2), single mutant (14M-15), and triple mutant proteins to immobilized AMA1.
Nuttall, S. D., Humberstone, K. S., Krishnan, U. V., Carmichael, J. A., Doughty, L., Hattarki, M., ... & Irving, R. A. (2004). Selection and affinity maturation of IgNAR variable domains targeting Plasmodium falciparum AMA1. PROTEINS: Structure, Function, and Bioinformatics, 55(1), 187-197.
Figure 4 Binding was measured at a constant flow rate of 5 ul/min with an injection volume of 35 ul. Dissociation was continued with HBS buffer until the response returned to the initial value before injecting the next sample
V(NAR)s 12Y-1 and 12Y-2 are specific for P. falciparum AMA1.
Nuttall, S. D., Humberstone, K. S., Krishnan, U. V., Carmichael, J. A., Doughty, L., Hattarki, M., ... & Irving, R. A. (2004). Selection and affinity maturation of IgNAR variable domains targeting Plasmodium falciparum AMA1. PROTEINS: Structure, Function, and Bioinformatics, 55(1), 187-197.
Figure 5 Binding was measured at a constant flow rate of 5 ul/min with an injection volume of 35 ul. Dissociation was continued with HBS buffer until the response returned to the initial value before injecting the next sample
V(NAR)s 12Y-1 and 12Y-2 are specific for P. falciparum AMA1.
Nuttall, S. D., Humberstone, K. S., Krishnan, U. V., Carmichael, J. A., Doughty, L., Hattarki, M., ... & Irving, R. A. (2004). Selection and affinity maturation of IgNAR variable domains targeting Plasmodium falciparum AMA1. PROTEINS: Structure, Function, and Bioinformatics, 55(1), 187-197.
Figure 6 IgNAR constant domain 1 is insufficient for dimer formation.
BIAcore sensorgrams comparing binding of proteins 17T-6 and 12Y-2 to immobilised AMA1 protein.
Simmons, D. P., Abregu, F. A., Krishnan, U. V., Proll, D. F., Streltsov, V. A., Doughty, L., ... & Nuttall, S. D. (2006). Dimerisation strategies for shark IgNAR single domain antibody fragments. Journal of immunological methods, 315(1-2), 171-184.
Figure 7 Dhlx-mediated dimerisation.
The peak-purified dimer fraction was analysed by BIAcore biosensor, compared to the parental 12Y-2
Simmons, D. P., Abregu, F. A., Krishnan, U. V., Proll, D. F., Streltsov, V. A., Doughty, L., ... & Nuttall, S. D. (2006). Dimerisation strategies for shark IgNAR single domain antibody fragments. Journal of immunological methods, 315(1-2), 171-184.
Figure 8 Tandem V(NAR)s in a single chain format
BIAcore sensorgrams comparing binding of proteins 12Y-2, 14M-15, and 15Q-1 to immobilised AMA1 protein.
Simmons, D. P., Abregu, F. A., Krishnan, U. V., Proll, D. F., Streltsov, V. A., Doughty, L., ... & Nuttall, S. D. (2006). Dimerisation strategies for shark IgNAR single domain antibody fragments. Journal of immunological methods, 315(1-2), 171-184.
Figure 9 ELISA analysis of 40 12Y-2 variants binding to AMA-1 and a control negative antigen.
ELISA analysis of 40 12Y-2 variants binding to AMA-1 and a control negative antigen.
Figure 10 Parasite Invasion Inhibition
Recombinant V(NAR) domains inhibit invasion of erythrocytes by P. falciparum 3D7 parasites. Data are represented as the mean ± standard error of quadruplicate experiments.
Henderson, K. A., Streltsov, V. A., Coley, A. M., Dolezal, O., Hudson, P. J., Batchelor, A. H., ... & Foley, M. (2007). Structure of an IgNAR-AMA1 complex: targeting a conserved hydrophobic cleft broadens malarial strain recognition. Structure, 15(11), 1452-1466.
Figure 11 Parasite Invasion Inhibition
Recombinant V(NAR) domains inhibit invasion of erythrocytes by P. falciparum 3D7 parasites. Data are represented as the mean ± standard error of quadruplicate experiments,except for P. falciparum W2mef parasites.
Henderson, K. A., Streltsov, V. A., Coley, A. M., Dolezal, O., Hudson, P. J., Batchelor, A. H., ... & Foley, M. (2007). Structure of an IgNAR-AMA1 complex: targeting a conserved hydrophobic cleft broadens malarial strain recognition. Structure, 15(11), 1452-1466.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
PABL-293 | Recombinant Rat Anti-P. Knowlesi AMA-1 Antibody (R31C2 ) | WB, BL, FuncS | IgG |
PABW-097 | Recombinant Mouse Anti-P. falciparum AMA1 Antibody (1F9) | ELISA, BL | IgG |
PABZ-098 | Recombinant Mouse Anti-P. vivax AMA-1 Antibody (F8.12.19) | IF | IgG |
PABZ-148 | Recombinant Mouse Anti-P. vivax AMA1 Antibody (F8.12.19) | WB | IgG |
PABL-397 | Human Anti-AMA1 Recombinant Antibody (PABL-397) | WB, ELISA, FuncS | Human IgG |
There are currently no Customer reviews or questions for MRO-191CT. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.